| OA21.03 | Using an HIV risk assessment tool to increase frequency of HIV testing in men who have sex with men in Beijing, China: an app-based randomized, controlled trial | Oral Abstract Session | Clinical trial results |
| OA21.02 | Methadone program participation and current ART use among people who inject drugs in Kenya | Oral Abstract Session | Discovery and evaluation of biomedical agents |
| OA21.01 | Effect of navigation services to achieve viral suppression among men who have sex with men (MSM) and transwomen living with HIV who attend public HIV care services in Lima, Peru | Oral Abstract Session | Implementation science, including structural interventions, PrEP & VMMC |
| OA20.05 | HIV-1 infection and the control of viral replication are associated with greater expression of interleukin-21 receptor on CD8+ T cells | Oral Abstract Session | Cellular immunity |
| OA20.04 | Tissue-resident memory CD4+ T cells in ectocervical versus endocervical specimens | Oral Abstract Session | Mucosal immunity |
| OA20.03 | Immune perturbation is more profound in newborn than in infant macaques during acute SHIV infection | Oral Abstract Session | Preclinical studies for HIV prevention |
| OA20.02 | HIV-resistant dual CD28/4-1BB costimulated CAR T cells mitigate HIV pathogenesis in humanized mice | Oral Abstract Session | Cellular immunity |
| OA20.01 | Alternative T cell effector functions are linked to humoral responses to HIV infection | Oral Abstract Session | Cellular immunity |
| OA19.05LB | Pharmacokinetic and pharmacodynamic study of tenofovir and tenofovir alafenamide for PrEP in foreskin tissue | Oral Abstract Session | Pharmacology/PK and PD studies |
| OA19.04LB | Silk fibroin as a mucosal delivery vehicle for Griffithsin and antiviral compounds: effective protection of macaques and high acceptance among user groups | Oral Abstract Session | Delivery technologies: novel approaches, formulation and multi-purpose |